BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12620410)

  • 1. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.
    So CW; Karsunky H; Passegué E; Cozzio A; Weissman IL; Cleary ML
    Cancer Cell; 2003 Feb; 3(2):161-71. PubMed ID: 12620410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
    So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
    Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The small oligomerization domain of gephyrin converts MLL to an oncogene.
    Eguchi M; Eguchi-Ishimae M; Greaves M
    Blood; 2004 May; 103(10):3876-82. PubMed ID: 14751928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
    Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
    Lavau C; Luo RT; Du C; Thirman MJ
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10984-9. PubMed ID: 10995463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common mechanism for oncogenic activation of MLL by forkhead family proteins.
    So CW; Cleary ML
    Blood; 2003 Jan; 101(2):633-9. PubMed ID: 12393557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
    Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
    Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
    DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
    Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
    J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
    So CW; Lin M; Ayton PM; Chen EH; Cleary ML
    Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
    Ayton PM; Cleary ML
    Oncogene; 2001 Sep; 20(40):5695-707. PubMed ID: 11607819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
    Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
    Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
    Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
    Cozzio A; Passegué E; Ayton PM; Karsunky H; Cleary ML; Weissman IL
    Genes Dev; 2003 Dec; 17(24):3029-35. PubMed ID: 14701873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
    Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
    Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
    So CW; Cleary ML
    Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
    Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.
    Buechele C; Breese EH; Schneidawind D; Lin CH; Jeong J; Duque-Afonso J; Wong SH; Smith KS; Negrin RS; Porteus M; Cleary ML
    Blood; 2015 Oct; 126(14):1683-94. PubMed ID: 26311362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
    Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
    Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.